ArticleEntropy (Basel, Switzerland)2022
Instance Segmentation of Multiple Myeloma Cells Using Deep-Wise Data Augmentation and Mask R-CNN.
Article in Entropy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Data Augmentation and Synthetic Data Generation in Rare Disease Research: A Scoping Review.Medical sciences (Basel, Switzerland) · 2025Article
- Multiple myeloma segmentation net (MMNet): an encoder-decoder-based deep multiscale feature fusion model for multiple myeloma segmentation in magnetic resonance imaging.Quantitative imaging in medicine and surgery · 2024Article
- Enhancing diagnostic accuracy of multiple myeloma through ML-driven analysis of hematological slides: new dataset and identification model to support hematologists.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple myeloma is a condition of cancer in the bone marrow that can lead to dysfunction of the body and fatal expression in the patient. Manual microscopic analysis of abnormal plasma cells, also known as multiple myeloma cells, is one of the most commonly used diagnostic methods for multiple myeloma. However, as it is a manual process, it consumes too much effort and time. Besides, it has a higher chance of human errors. This paper presents a computer-aided detection and segmentation of myeloma cells from microscopic images of the bone marrow aspiration. Two major contributions are presented in this paper. First, different Mask R-CNN models using different images, including original microscopic images, contrast-enhanced images and stained cell images, are developed to perform instance segmentation of multiple myeloma cells. As a second contribution, a deep-wise augmentation, a deep learning-based data augmentation method, is applied to increase the performance of Mask R-CNN models. Based on the experimental findings, the Mask R-CNN model using contrast-enhanced images combined with the proposed deep-wise data augmentation provides a superior performance compared to other models. It achieves a mean precision of 0.9973, mean recall of 0.8631, and mean intersection over union (IOU) of 0.9062.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.